Quantitative identification of senescent cells in aging and disease.

Biran A, Zada L, Abou Karam P, Vadai E, Roitman L, Ovadya Y, Porat Z, Krizhanovsky V. · 2017

Read Quantitative identification of senescent cells in aging and disease. by Biran A, Zada L, Abou Karam P, Vadai E, Roitman L, Ovadya Y, Porat Z, Krizhanovsky V. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5506427.txt.

Introduction

Biran and co-authors present a methods study in Aging Cell on counting senescent cells. Senescent cells are worn-out cells that stop dividing yet linger in tissues. They build up with age and at damage sites. Counting them inside real tissue has been hard and imprecise. A single stain alone gives false positives.

The team paired the classic senescence stain with marker stains for cell identity. An imaging flow device then read every cell one by one. The method counted senescent cells in tumors and scarred tissue, they report. Old mouse tissues could be measured the same way. Senescent cells there proved larger than their neighbors. The tool opens screening for drugs that clear such cells.

Catalog record

CREATORBiran A, Zada L, Abou Karam P, Vadai E, Roitman L, Ovadya Y, Porat Z, Krizhanovsky V.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5506427

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Quantitative identification of senescent cells in aging and disease By Anat Biran, Lior Zada, Paula Abou Karam, Ezra Vadai, Lior Roitman, Yossi Ovadya, Ziv Porat, Valery Krizhanovsky Published in: Aging Cell DOI: 10.1111/acel.12592 ABSTRACT Summary Senescent cells are present in premalignant lesions and sites of tissue damage and accumulate in tissues with age. In vivo identification, quantification and characterization of senescent cells are challenging tasks that limit our understanding of the role of senescent cells in diseases and aging. Here, we present a new way to precisely quantify and identify senescent cells in tissues on a single‐cell basis. The method combines a senescence‐associated beta‐galactosidase assay with staining of molecular markers for cellular senescence and of cellular identity. By utilizing technology that combines flow cytometry with high‐content image analysis, we were able to quantify senescent cells in tumors, fibrotic tissues, and tissues of aged mice. Our approach also yielded the finding that senescent cells in tissues of aged mice are larger than nonsenescent cells. Thus, this method provides a basis for quantitative assessment of senescent cells and it offers proof of principle for combination of different markers of senescence. It paves the way for screening of senescent cells for identification of new senescence biomarkers, genes that bypass senescence or senolytic compounds that eliminate senescent cells, thus enabling a deeper understanding of the senescent state in vivo. INTRODUCTION Cellular senescence is a multifaceted phenomenon that functions in tumor suppression, wound healing, embryonic development, biological aging, and development of pro‐inflammatory age‐related diseases (Campisi, 2013; Burton & Krizhanovsky, 2014; Munoz‐Espin & Serrano, 2014; Salama et al., 2014). Cellular senescence is characterized by an altered cell state that is activated in response to persistent DNA damage triggered by various stimuli such as telomere shortening, activated oncogenes, oxidative stress, and cell–cell fusion. Senescent cells are likely to have either beneficial or detrimental effects within tissues, depending on whether the cells are transiently or persistently present. Our understanding of the role of cellular senescence in different biological contexts has been impeded in part by the difficulty of detecting their presence within tissues. Such detection is currently performed mainly by evaluation of senescence‐associated beta‐galactosidase (SA‐β‐gal) (Dimri et al., 1995; Debacq‐Chainiaux et al., 2009; Kuilman et al., 2010). However, SA‐β‐gal activity alone is not enough to allow us to conclude with confidence that cells are senescent, as positive staining can also occur in other biological contexts (Kuilman et al., 2010; Caldwell et al., 2011). Therefore, SA‐β‐gal staining is usually combined with staining for additional markers such as γH2AX—a marker for activation of DNA damage response. In addition, negative markers that should be absent in senescent cells can be used to exclude the cells that are not senescent. These markers indicate cell proliferation, like Ki67 or BrdU incorporation, or proteins ubiquitously present in the cell nuclei, but secreted from senescent cells and thus absent in their nucleus, like HGMB1 (Davalos et al., 2013). The SA‐β‐gal and each of the markers are usually evaluated separately in consecutive sections. This procedure is not only laborious and expensive but also does not allow multiple senescence biomarkers to be detected within the same cells, limiting the possibility of quantitative evaluation of senescent cells derived from tissues. Alternatively, SA‐β‐gal activity within cells can be quantified by flow cytometry using 5‐dodecanoylaminofluorescein di‐β‐D‐galactopyranoside as a substrate (Debacq‐Chainiaux et al., 2009). However, this method can be performed only on intact cells and therefore does not allow identification of intracellular markers in the same cells. Altogether, current methods do not allow detection and quantification of senescent cells in tissues based on combination of markers that is essential for their confident identification. Conventional SA‐β‐gal staining fails to distinguish between different cell types that can be a source of senescent cells within complex tissues, limiting our understanding of the underlying biological phenomena. In an attempt to overcome the limitations of current methods for identification of senescent cells, we utilized ImageStreamX, an advanced imaging flow cytometer capable of producing multiple high‐resolution, fluorescent and bright‐field (BF) images of every cell directly in flow. Our approach combines the quantitative power of flow cytometry with high‐content image analysis. We modified the traditional SA‐β‐gal assay to meet the requirements of the ImageStreamX and performed the assay in a single‐cell suspension. Using this method, we identified and quantified senescent cells in tumors, fibrotic tissues, and normal tissues of young and aged mice. RESULTS Utilizing ImageStreamX for the quantification of senescent cells To determine whether SA‐β‐gal staining can be detected and quantified using ImageStreamX technology, we subjected normal human BJ fibroblasts to DNA damage‐induced senescence by treating them with etoposide (DIS cells). Normal growing and DIS cells were fixed using either 4% paraformaldehyde (PFA) or 0.5% glutaraldehyde (GA) and were then stained for SA‐β‐gal and imaged by ImageStreamX. As a control, growing and DIS cells were fixed and analyzed without staining for SA‐β‐gal. Images of the cells revealed that the staining can be easily detected using bright‐field (BF) channel as cells positive for SA‐β‐gal appear in black (Figs 1A and S1A, Supporting information). To quantify the levels of SA‐β‐gal staining of each cell, we used the BF mean pixel feature, which exhibited superior separation ability compared with combinations of features (intensity, morphology, texture) with masks (Fig. 1B). The mean BF pixel intensity was calculated for each cell, such that SA‐β‐gal‐negative (bright) cells have high mean BF intensity, whereas SA‐β‐gal‐positive (black) cells have low mean BF intensity. Using either PFA or GA as the fixative agent, we observed a clear separation between DIS cells and growing‐untreated cells using ImageStreamX (Fig. 1B). To compare these results with a conventional microscopy, we subjected BJ cell suspensions to microscopic imaging. As expected, SA‐β‐gal‐positive cells were observed in DIS population (Fig. S1B, Supporting information). When fixed with PFA, SA‐β‐gal‐positive cells accounted for 89.6 ± 1.1% of DIS and for 4.8 ± 0.49% of growing BJ cells (P < 0.001) (Fig. 1C). Similar results were obtained when we used GA as the fixative agent (SA‐β‐gal positive in 4.1 ± 0.71% of growing and 86.9 ± 2.3% of DIS cells, P < 0.001) (Fig. 1C). The results are in line with those obtained when we quantified SA‐β‐gal‐positive cells by microscopy (Fig. S1C,D, Supporting information). Overall, these findings demonstrate that SA‐β‐gal staining can be detected and quantified using ImageStreamX. To determine whether this method of quantitation can be applied to cells induced to senesce by alternative stimuli, we used ionizing irradiation to induce BJ cells to senesce, and then stained them for SA‐β‐gal and analyzed them. ImageStreamX analysis revealed that 88.82 ± 3.2% of irradiated cells scored as SA‐β‐gal positive, compared with 4.7 ± 0.48% of growing cells used as controls (P < 0.0001, Fig. 1D). To test the ability of this assay to detect senescent cells obtained from different species, we performed the assay on mouse embryonic fibroblasts (MEFs). These cells were subjected to treatment with etoposide to induce senescence (DIS), fixed with either PFA or GA, and stained for SA‐β‐gal. With either PFA or GA used as the fixative agent, clear differences were observed in SA‐β‐gal staining between DIS and growing cells (Fig. 1E,F). Quantification of SA‐β‐gal‐positive cells revealed that 93.0 ± 2.3% of DIS cells and 8.1 ± 1.0% of growing MEFs were

Read the complete text